Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Caroline A. Hartill currently holds 96,430 shares of RTI Biologics, Inc. (RTIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Caroline A. Hartill has been a net buyer of RTIX stock. They have purchased $3.1K and sold $0 worth of shares.
Caroline A. Hartill's most recent insider trade was on Jan 31, 2017, when they sold 25,834 shares at $3.25 per share.
Caroline A. Hartill serves as Executive at RTI Biologics, Inc. (RTIX). They have executed 18 insider transactions totaling $3.1K over their tenure at the company.
Caroline A. Hartill holds the position of Executive at RTI Biologics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Caroline A. Hartill has shown a buying trading pattern, with $3.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Caroline A. Hartill was on May 29, 2015, when they sold $311.1K worth of RTIX shares. This transaction involved 48,080 shares at $6.47 per share.
Caroline A. Hartill currently owns 96,430 shares of RTI Biologics, Inc. (RTIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Caroline A. Hartill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Caroline A. Hartill has 18 Form 4 filings on record as an insider at RTI Biologics, Inc..
Set alerts for Caroline A. Hartill and 40,000+ other insiders.